Cerebral Small Vessel Disease Professional Committee Consensus Writing Group, Chinese Research Hospital Association. Chinese Consensus on Diagnosis and Therapy of Cerebral Small Vessel Disease 2021[J]. Chinese Journal of Stroke, 2021, 16(07): 716-726.
[1] 中华医学会神经病学分会,中华医学会神经病学分
会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华
神经科杂志,2015,48(10):838-844.
[2] PANTONI L. Cerebral small vessel disease:from
pathogenesis and clinical characteristics to
therapeutic challenges[J]. Lancet Neurol,2010,9
(7):689-701.
[3] WARDLAW J M,SMITH E E,BIESSELS G J,et
al. Neuroimaging standards for research into small
vessel disease and its contribution to ageing and
neurodegeneration[J]. Lancet Neurol,2013,12(8):
822-838.
[4] WU S M,WU B,LIU M,et al. Stroke in China:
advances and challenges in epidemiology,prevention,
and management[J]. Lancet Neurol,2019,18(4):
394-405.
[5] POELS M M F,VERNOOIJ M W,IKRAM M
A,et al. Prevalence and risk factors of cerebral
microbleeds:an update of the Rotterdam scan
study[J/OL]. Stroke,2010,41(10 Suppl):
S103-S106[2021-06-17]. https://doi.org/10.1161/
strokeaha.110.595181.
[6] ZHANG C Q,CHEN Q D,WANG Y L,et al. Risk
factors of dilated Virchow-Robin spaces are different
in various brain regions[J/OL]. PLoS One,2014,9
(8):e105505[2021-06-17]. https://doi.org/10.1371/
journal.pone.0105505.
[7] WANG Y L,XU J,ZHAO X Q,et al. Association
of hypertension with stroke recurrence depends on
ischemic stroke subtype[J]. Stroke,2013,44(5):
1232-1237.
[8] MA Y,SONG A,VISWANATHAN A,et al. Blood
pressure variability and cerebral small vessel disease:
a systematic review and meta-analysis of populationbased
cohorts[J]. Stroke,2020,51(1):82-89.
[9] IADECOLA C. The neurovascular unit coming of
age:a journey through neurovascular coupling in
health and disease[J]. Neuron,2017,96(1):17-42.
[10] MORAN C,PHAN T G,SRIKANTH V K.
Cerebral small vessel disease:a review of clinical,
radiological,and histopathological phenotypes[J].
Int J Stroke,2012,7(1):36-46.
[11] 牛世芹,秦伟,杨淑娜,等. 脑小血管病导致运动障
碍的研究进展[J]. 中华老年心脑血管病杂志,2019,
21(6):670-672.
[12] SCHMIDT R,BERGHOLD A,JOKINEN H,et al.
White matter lesion progression in LADIS:frequency,
clinical effects,and sample size calculations[J].
Stroke,2012,43(10):2643-2647.
[13] LADIS Study Group. 2001–2011:a decade of the
LADIS(Leukoaraiosis And DISability)Study:what
have we learned about white matter changes and
small-vessel disease?[J]. Cerebrovas Dis,2011,32
(6):577-588.
[14] VAN ES A C,VAN DER GROND J,DE CRAEN
A J M,et al. Cerebral microbleeds and cognitive
functioning in the PROSPER study[J]. Neurology,
2011,77(15):1446-1452.
[15] NANNONI S,OHLMEIER L,BROWN R B,et al.
Cognitive impact of cerebral microbleeds in patients
with symptomatic small vessel disease[J/OL]. Int J
Stroke,2021:17474930211012837[2021-06-17].
https://doi.org/10.1177/17474930211012837.
[16] DE LAAT K F,VAN DEN BERG H A C,VAN
NORDEN A G W,et al. Microbleeds are
independently related to gait disturbances in elderly
individuals with cerebral small vessel disease[J].
Stroke,2011,42(2):494-497.
[17] PASSIAK B S,LIU D,KRESGE H A,et al.
Perivascular spaces contribute to cognition beyond
other small vessel disease markers[J/OL]. Neurology,
2019,92(12):e1309-e1321[2021-06-17]. https://doi.
org/10.1212/wnl.0000000000007124.
[18] HILAL S,TAN C S,ADAMS H H H,et al.
Enlarged perivascular spaces and cognition:a
meta-analysis of 5 population-based studies[J/OL].
Neurology,2018,91(9):e832-e842[2021-06-17].
https://doi.org/10.1212/wnl.0000000000006079.
[19] SCHELTENS P,BARKHOF F,LEYS D,et al.
A semiquantative rating scale for the assessment
of signal hyperintensities on magnetic resonance
imaging[J]. J Neurol Sci,1993,114(1):7-12.
[20] VAN STRAATEN E,FAZEKAS F,ROSTRUP E,
et al. Impact of white matter hyperintensities scoring
method on correlations with clinical data:the
LADIS study[J]. Stroke,2006,37(3):836-840.
[21] GREGOIRE S,CHAUDHARY U,BROWN M,et
al. The microbleed anatomical rating scale(MARS):
reliability of a tool to map brain microbleeds[J].
Neurology,2009,73(21):1759-1766.
[22] CORDONNIER C,POTTER G,JACKSON C,et
al. Improving interrater agreement about brain
microbleeds:development of the brain observer
microbleed scale(BOMBS)[J]. Stroke,2009,40
(1):94-99.
[23] DUERING M,FINSTERWALDER S,BAYKARA
E,et al. Free water determines diffusion alterations
and clinical status in cerebral small vessel disease[J].
Alzheimers Dement,2018,14(6):764-774.
[24] REIJMER Y,FOTIADIS P,MARTINEZRAMIREZ
S,et al. Structural network alterations
and neurological dysfunction in cerebral amyloid
angiopathy[J/OL]. Brain,2015,138(Pt 1):179-
188[2021-06-17]. https://doi.org/10.1093/brain/
awu316.
[25] LI Y X,WANG D F,ZHANG H Y,et al. Changes
of brain connectivity in the primary motor cortex
after subcortical stroke:a multimodal magnetic
resonance imaging study[J/OL]. Medicine,2016,95
(6):e2579[2021-06-17]. https://doi.org/10.1097/md.
0000000000002579.
[26] LI Y,LI M,ZUO L,et al. Compromised blood-brain
barrier integrity is associated with total magnetic
resonance imaging burden of cerebral small vessel
disease[J/OL]. Front Neurol,2018,9:221[2021-06-
17]. https://doi.org/10.3389/fneur.2018.00221.
[27] 中华医学会老年医学分会老年神经病学组,脑小血
管病认知功能障碍诊疗指南中国撰写专家组. 脑小
血管病相关认知功能障碍中国诊疗指南(2019)[J].
中华老年医学杂志,2019,38(4):345-354.
[28] 乔杉杉,张拥波,赵莹莹,等. 脑小血管病临床生化
标志物研究进展[J]. 临床和实验医学杂志,2020,19
(6):671-673.
[29] MARINI S,ANDERSON C,ROSAND J. Genetics
of cerebral small vessel disease[J]. Stroke,2020,51
(1):12-20.
[30] STAALS J,MAKIN S D J,DOUBAL F N,et al.
Stroke subtype,vascular risk factors,and total MRI
brain small-vessel disease burden[J]. Neurology,
2014,83(14):1228-1234.
[31] FAZEKAS F,CHAWLUK J B,ALAVI A,et al. MR
signal abnormalities at 1.5 T in Alzheimer's dementia
and normal aging[J]. AJR Am J Roentgenol,1987,
149(2):351-356.
[32] DOUBAL F N,MACLULLICH A M J,FERGUSON
K J,et al. Enlarged perivascular spaces on MRI are
a feature of cerebral small vessel disease[J]. Stroke,
2010,41(3):450-454.
[33] YANG S N,YUAN J L,QIN W,et al. Twentyfour-
hour ambulatory blood pressure variability is
associated with total magnetic resonance imaging
burden of cerebral small-vessel disease[J/OL]. Clin
Interv Aging,2018,13:1419-1427[2021-06-17].
https://doi.org/10.2147/CIA.S171261.
[34] SØNDERGAARD C B,NIELSEN J E,HANSEN
C K,et al. Hereditary cerebral small vessel disease
and stroke[J/OL]. Clin Neurol Neurosurg,2017,155:
45-57[2021-06-17]. https://doi.org/10.1016/j.clineuro.
2017.02.015.
[35] ODDEN M C,MCCLURE L A,SAWAYA B P,et
al. Achieved blood pressure and outcomes in the
secondary prevention of small subcortical strokes
trial[J]. Hypertension,2016,67(1):63-69.
[36] DECARLI C. Blood pressure control and cognitive
performance:something to think about with
aging[J]. JAMA,2015,313(19):1963-1964.
[37] CHEN X,ZHU Y Q,GENG S S,et al. Association
of blood pressure variability and intima-media
thickness with white matter hyperintensities in
hypertensive patients[J/OL]. Front Aging Neurosci,
2019,11:192[2021-06-17]. https://doi.org/10.3389/
fnagi.2019.00192.
[38] ZHANG H,CUI Y,ZHAO Y X,et al. Association
of circadian rhythm of blood pressure and cerebral
small vessel disease in community-based elderly
population[J]. J Gerontol A Biol Sci Med Sci,2019,
74(8):1322-1330.
[39] YANG S A,YUAN J L,ZHANG X Y,et al. Higher
ambulatory systolic blood pressure independently
associated with enlarged perivascular spaces in basal
ganglia[J]. Neurol Res,2017,39(9):787-794.
[40] KU E,SCHERZER R,ODDEN M C,et al. Patterns
of blood pressure response during intensive BP
lowering and clinical events:results from the
secondary prevention of small subcortical strokes
trial[J]. Blood Press,2018,27(2):73-81.
[41] WEBB A J S,FISCHER U,MEHTA Z,et
al. Effects of antihypertensive-drug class on
interindividual variation in blood pressure and risk
of stroke:a systematic review and meta-analysis[J].
Lancet,2010,375(9718):906-915.
[42] POWERS W J,RABINSTEIN A A,ACKERSON
T,et al. 2018 Guidelines for the early management of
patients with acute ischemic stroke:a guideline for
healthcare professionals from the American Heart
Association/American Stroke Association[J/OL].
Stroke,2018,49(3):e46-e110[2021-06-17].
https://doi.org/10.1161/str.0000000000000158.
[43] 中华医学会神经病学分会,中华医学会神经病学分
会脑血管病学组. 中国急性缺血性脑卒中诊治指南
2018[J]. 中华神经科杂志,2018,51(9):666-682.
[44] KIM B J,KWON S U,PARK J-H,et al. Cilostazol
versus aspirin in ischemic stroke patients with highrisk
cerebral hemorrhage:subgroup analysis of the
PICASSO trial[J]. Stroke,2020,51(3):931-937.
[45] AMARENCO P,BENAVENTE O,GOLDSTEIN
L B,et al. Results of the stroke prevention by
aggressive reduction in cholesterol levels(SPARCL)
trial by stroke subtypes[J]. Stroke,2009,40(4):
1405-1409.
[46] XIONG Y Y,WONG A,CAVALIERI M,et
al. Prestroke statins,progression of white
matter hyperintensities,and cognitive decline
in stroke patients with confluent white matter
hyperintensities[J]. Neurotherapeutics,2014,11(3):
606-611.
[47] TEN DAM V H,VAN DEN HEUVEL D M J,
VAN BUCHEM M A,et al. Effect of pravastatin
on cerebral infarcts and white matter lesions[J].
Neurology,2005,64(10):1807-1809.
[48] Heart Protection Study Collaborative Group. MRC/
BHF heart protection study of cholesterol lowering
with simvastatin in 20,536 high-risk individuals:a
randomised placebo-controlled trial[J]. Lancet,2002,
360(9326):7-22.
[49] PEZZINI A,GRASSI M,IACOVIELLO L,et al.
Serum cholesterol levels,HMG-CoA reductase
inhibitors and the risk of intracerebral haemorrhage.
the multicenter study on cerebral haemorrhage
in Italy(MUCH-Italy)[J]. J Neurol Neurosurg
Psychiatry,2016,87(9):924-929.
[50] ZHANG J L,LIU N N,YANG C Q. Effects of
rosuvastatin in combination with nimodipine in
patients with mild cognitive impairment caused by
cerebral small vessel disease[J]. Panminerva Med,
2019,61(4):439-443.
[51] ZHANG H,CUI Y,ZHAO Y X,et al. Effects
of sartans and low-dose statins on cerebral white
matter hyperintensities and cognitive function in
older patients with hypertension:a randomized,
double-blind and placebo-controlled clinical trial[J].
Hypertens Res,2019,42(5):717-729.
[52] JIAN B H,HU M Y,CAI W,et al. Update of
immunosenescence in cerebral small vessel disease[J/
OL]. Front Immunol,2020,11:585655[2021-06-17].
https://doi.org/10.3389/fimmu.2020.585655.
[53] CAVALIERI M,SCHMIDT R,CHEN C,et al. B
vitamins and magnetic resonance imaging-detected
ischemic brain lesions in patients with recent
transient ischemic attack or stroke:the VITAmins
TO Prevent Stroke(VITATOPS)MRI-substudy[J].
Stroke,2012,43(12):3266-3270.